FORH
from 955 today
Fortis healthcare delivered in-line 1QFY27 performance with robust growth in the core hospital business driven by patient volume, while diagnostics was driven by improved realization. We maintain our estimates and SOTP-based target price of INR1,130, and maintain our BUY rating.
Ratings and target prices as published by each firm. Each summary condenses that firm's stated view in its own note and is attributed to it; no report text is reproduced.
